Publications by authors named "Azza Mostafa Ibrahim"

Unlabelled: Different therapeutic techniques have been developed for regeneration of articular cartilage injuries, but none has provided an optimal solution to their treatment. Human umbilical cord blood-mesenchymal Stem Cells (HUCB-MSCs) have been considered as promising alternative cell source for cartilage repair.

Objectives: Examining the success rate of MSCs isolation from HUCB as well as chondrogenic differentiation potential of HUCB-MSCs in vitro.

View Article and Find Full Text PDF

Apoptosis deregulation is important for cancer development, chemotherapy response, and prognosis. Survivin and X-linked inhibitor of apoptosis protein (XIAP) are 2 members of the inhibitor of apoptosis proteins family (IAP). We used semi-quantitative reverse transcriptase polymerase chain reaction (RT-PCR) to determine the levels of expression of survivin and XIAP in 30 patients with de novo acute myeloid leukemia (AML) and 20 age- and sex-matched healthy volunteers.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Azza Mostafa Ibrahim"

  • - Azza Mostafa Ibrahim's research primarily focuses on the therapeutic potential of stem cells and their role in cancer, emphasizing the differentiation capabilities of human umbilical cord blood-derived mesenchymal stem cells (HUCB-MSCs) for articular cartilage repair.
  • - In her 2015 study, Ibrahim investigated the efficacy of isolating MSCs from HUCB and assessed their ability to undergo chondrogenic differentiation, proposing these cells as a viable alternative for treating cartilage injuries.
  • - Her earlier work in 2012 explored the expression levels of survivin and XIAP genes in acute myeloid leukemia (AML), highlighting the importance of apoptosis deregulation in cancer progression and response to treatment.